scholarly journals Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study

2010 ◽  
Vol 65 (4) ◽  
pp. 735-740 ◽  
Author(s):  
L. Milazzo ◽  
I. Caramma ◽  
C. Mazzali ◽  
M. Cesari ◽  
M. Olivetti ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Open Label ◽  
Randomized Controlled

scholarly journals A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3

SpringerPlus ◽  
2016 ◽  
Vol 5 (1) ◽  
Author(s):  
Graham R. Foster ◽  
Kazuaki Chayama ◽  
Wan-Long Chuang ◽  
Hugo Fainboim ◽  
Martti Farkkila ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Virus Genotype ◽  
Randomized Controlled ◽  
Genotype 2

scholarly journals Long-term Pegylated Interferon Monotherapy Following 72 Weeks of Pegylated Interferon and Ribavirin in Hepatitis C Virus Genotype-1-infected Slow Responders

2015 ◽  
Vol 54 (3) ◽  
pp. 273-279 ◽  
Author(s):  
Shinya Watanabe ◽  
Yoshimasa Kobayashi ◽  
Kazuhito Kawata ◽  
Hidenao Noritake ◽  
Takeshi Chida ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Interferon Monotherapy
Sign in / Sign up

Export Citation Format

Share Document